Effectiveness and factors associated with response to golimumab in Japanese patients with ulcerative colitis in real clinical practice: Phoenix Study

Effectiveness and factors associated with response to golimumab in Japanese patients with ulcerative colitis in real clinical practice: Phoenix Study

Abstract Introduction: There have been limited reports on the clinical efficacy of golimumab (GLM) in Japanese patients with ulcerative colitis (UC) in real clinical practice. This study aimed to explore the real-life effectiveness and factors associated with response to GLM in Japanese patients wit...

Full description

Bibliographic Details
Main Authors:	Daisuke Hirayama, Satoshi Motoya, Toshifumi Ashida, Katsuyoshi Ando, Mikihiro Fujiya, Takahiro Ito, Shigeru Furukawa, Atsuo Maemoto, Takehiko Katsurada, Shiro Hinotsu, Noriko Sato, Naomi Mizuno, Yoshiko Ikawa, Hiroshi Nakase
Format:	Article
Language:	English
Published:	Karger Publishers 2023-08-01
Series:	Inflammatory Intestinal Diseases
Online Access:	https://beta.karger.com/Article/FullText/533871

Similar Items

Long-term effectiveness and safety of infliximab-biosimilar: A multicenter Phoenix retrospective cohort study.
by: Tomoe Kazama, et al.
Published: (2023-01-01)

Efficacy and safety of abrilumab, an α4β7 integrin inhibitor, in Japanese patients with moderate-to-severe ulcerative colitis: a phase II study
by: Toshifumi Hibi, et al.
Published: (2019-07-01)

Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
by: Kensuke Sakurai, et al.
Published: (2022-01-01)

Golimumab in the treatment of ulcerative colitis
by: Georgina Cunningham, et al.
Published: (2019-01-01)

Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01)

Golimumab Therapy in Ulcerative Colitis
by: Won Moon
Published: (2016-02-01)

Golimumab for the treatment of ulcerative colitis
by: Löwenberg M, et al.
Published: (2014-03-01)

Monitoring of leucine‐rich alpha‐2‐glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients
by: Takahiro Ito, et al.
Published: (2023-09-01)

GOLIMUMAB SAFETY ACCORDING TO CLINICAL FINDINGS
by: G. V. Lukina, et al.
Published: (2015-04-01)

The abilities of golimumab in the therapy of ankylosing spondylitis
by: Sh. F. Erdes
Published: (2014-09-01)

Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
by: Taylor, P, et al.
Published: (2011)

Golimumab in the treatment of psoriatic arthritis: efficacy and safety
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2015-09-01)

Safety and clinical efficacy of golimumab in the treatment of arthritides
by: Ismail Simsek, et al.
Published: (2010-09-01)

Correction: Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
by: Hitoshi Tajiri, et al.
Published: (2022-01-01)

Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
by: Proton Rahman, et al.
Published: (2020-09-01)

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
by: Naohiko Kinoshita, et al.
Published: (2022-08-01)

Efficacy of golimumab in patients with refractory non-infectious panuveitis
by: Usanee Tungsattayathitthan, et al.
Published: (2024-01-01)

THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2018-03-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)

Golimumab in the treatment of extra-skeletal manifestations of ankylosing spondylitis
by: A. B. Demina
Published: (2019-10-01)

Golimumab pharmacokinetics in ulcerative colitis: a literature review
by: Ines Harzallah, et al.
Published: (2017-01-01)

Initial experience with golimumab in clinical practice for ulcerative colitis
by: Luisa Castro-Laria, et al.

Successful medical treatment for a Crohn’s disease patient with a perforation by a second-generation patency capsule
by: Hiroki Tanabe, et al.
Published: (2018-12-01)

Effectiveness and Safety of Golimumab in the Treatment of Ulcerative Colitis: 52-week Results from Post-marketing Surveillance in Japan
by: Shiro Nakamura, et al.
Published: (2022-11-01)

Real-world data for golimumab treatment in patients with ulcerative colitis in Japan: interim analysis in post-marketing surveillance
by: Shiro Nakamura, et al.
Published: (2022-07-01)

An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016-07-01)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021-08-01)

Cancer Research in Adenocarcinoma, Adenoma, Adenomatous Polyposis Coli, and Colitis-Associated Neoplasia: A Special Issue
by: Kentaro Moriichi, et al.
Published: (2023-02-01)

GOLIMUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: Wordsworth, P, et al.
Published: (2009)

Effect of golimumab on endothelial vasomotor function and arterial stiffness in ankylosing spondylitis
by: L. A. Knyazeva, et al.
Published: (2019-07-01)

Golimumab (anti-TNF monoclonal antibody): where we stand today
by: Ana Teresa Melo, et al.
Published: (2021-06-01)

The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
by: Natalia Vladimirovna Chichasova
Published: (2014-12-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
by: Melissa A Michelon, et al.
Published: (2010-05-01)

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials
by: Toussirot E, et al.
Published: (2016-07-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
by: M. Rossini, et al.
Published: (2015-03-01)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
by: Pugliese D, et al.
Published: (2016-02-01)

Early identification of golimumab-treated patients with higher likelihood of long-term retention
by: Alicia García-Dorta, et al.
Published: (2024-04-01)

Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis
by: Kojima S, et al.
Published: (2024-01-01)

Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations
by: Sydney Moore McIntosh, et al.
Published: (2023-07-01)